Oikari Sanna, Ahtialansaari Tiia, Heinonen Miika V, Mauriala Timo, Auriola Seppo, Kiehne Karlheinz, Fölsch Ulrich R, Jänne Juhani, Alhonen Leena, Herzig Karl-Heinz
Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute, University of Kuopio, P.O. Box 1627, 70211 Kuopio, Finland.
Pflugers Arch. 2008 May;456(2):369-77. doi: 10.1007/s00424-007-0416-y. Epub 2007 Dec 22.
Acyl-CoA-binding protein (ACBP) acts as an acyl-CoA pool former, transporter, and regulator of gene transcription in vitro. We created a transgenic rat line overexpressing ACBP, as the physiological relevance of ACBP in lipid metabolism is unclear. Transgenic rats revealed increased levels of ACBP and significantly elevated acyl-CoA tissue levels while there was no effect on plasma triglyceride, cholesterol, or serum-free fatty acid levels. Metabolic regulators like peroxisome proliferator-activated receptors (PPARgamma, PPARdelta) and sterol regulatory element-binding protein-1 (SREBP-1) messenger RNA levels were significantly reduced (by 23-82%) in liver and adipose tissue of fed transgenic rats, whereas adenosine monophosphate-activated protein kinase (AMPK) protein levels were increased (by 60%). Fasting abolished PPAR downregulation in liver and caused an upregulation in adipose tissue. Administration of AMPK inhibitor reversed SREBP-1 but did not affect PPAR regulation. In conclusion, ACBP acts as an acyl-CoA pool former in transgenic rats and regulates lipid metabolism via SREBP-1 and PPAR regulation. Reduction of SREBP-1 is mediated via increased AMPK levels, whereas regulation of PPARs seems to be mediated by an AMPK-independent mechanism. ACBP itself is a target gene for both transcription factors demonstrating important feedback loops.
酰基辅酶A结合蛋白(ACBP)在体外可作为酰基辅酶A库的形成者、转运体和基因转录调节因子。由于ACBP在脂质代谢中的生理相关性尚不清楚,我们构建了一种过表达ACBP的转基因大鼠品系。转基因大鼠显示ACBP水平升高,酰基辅酶A组织水平显著升高,而对血浆甘油三酯、胆固醇或血清游离脂肪酸水平没有影响。在喂食的转基因大鼠的肝脏和脂肪组织中,过氧化物酶体增殖物激活受体(PPARγ、PPARδ)和固醇调节元件结合蛋白-1(SREBP-1)等代谢调节因子的信使核糖核酸水平显著降低(降低23%-82%),而腺苷单磷酸激活蛋白激酶(AMPK)的蛋白水平升高(升高60%)。禁食消除了肝脏中PPAR的下调,并导致脂肪组织中PPAR上调。给予AMPK抑制剂可逆转SREBP-1的变化,但不影响PPAR的调节。总之,ACBP在转基因大鼠中作为酰基辅酶A库的形成者,并通过SREBP-1和PPAR调节来调控脂质代谢。SREBP-1的降低是通过增加AMPK水平介导的,而PPAR的调节似乎是由一种不依赖AMPK的机制介导的。ACBP本身是这两种转录因子的靶基因,显示出重要的反馈回路。